Clinical Trial Update: Autologous Hematopoietic Cell Transplantation for Core-binding Factor (CBF) Acute Myeloid Leukemia (AML) in the First Complete Remission (CR1) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous hematopoietic stem cell transplantation for core-binding factor acute myeloid leukemia in first complete remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Autologous hematopoietic cell transplantation

Snippet

Sponsor: Cooperative Study Group A for Hematology | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN